New combo therapy shows promise for rare chest cancer

This study tests whether combining the drug envolizumab with radiation therapy before surgery can safely shrink tumors in people with locally advanced thymic carcinoma. About 25 adults aged 18-75 with stage III-IVA disease who have not had prior treatment will receive the combination, then undergo surgery. The goal is to see how many patients have their tumors shrink or disappear, and to establish better treatment standards for this rare cancer.